Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126065321 | 12606532 | 1 | I | 20160728 | 20160729 | 20160729 | EXP | US-ROCHE-1804545 | ROCHE | 62.00 | YR | F | Y | 78.00000 | KG | 20160729 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126065321 | 12606532 | 1 | PS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Subcutaneous | 103964 | |||||||||||
| 126065321 | 12606532 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 21511 | |||||||||||
| 126065321 | 12606532 | 3 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | 0 | 400 | MG | TABLET | ||||||||
| 126065321 | 12606532 | 4 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | 0 | 400 | MG | TABLET | ||||||||
| 126065321 | 12606532 | 5 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 126065321 | 12606532 | 6 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | 0 | ||||||||||||
| 126065321 | 12606532 | 7 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 126065321 | 12606532 | 8 | C | HYDRODIURIL | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 126065321 | 12606532 | 9 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 126065321 | 12606532 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126065321 | 12606532 | 11 | C | CLARITIN (UNITED STATES) | 2 | 0 | |||||||||||||
| 126065321 | 12606532 | 12 | C | MOBIC | MELOXICAM | 1 | 0 | ||||||||||||
| 126065321 | 12606532 | 13 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 126065321 | 12606532 | 14 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126065321 | 12606532 | 1 | Hepatitis C |
| 126065321 | 12606532 | 2 | Hepatitis C |
| 126065321 | 12606532 | 3 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126065321 | 12606532 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126065321 | 12606532 | Drug ineffective | |
| 126065321 | 12606532 | Viral load increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126065321 | 12606532 | 1 | 20140909 | 20141125 | 0 | |
| 126065321 | 12606532 | 2 | 20140909 | 20141202 | 0 | |
| 126065321 | 12606532 | 3 | 20140909 | 20141202 | 0 | |
| 126065321 | 12606532 | 4 | 20160324 | 0 |